CN103705783A - Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate - Google Patents
Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate Download PDFInfo
- Publication number
- CN103705783A CN103705783A CN201410005480.0A CN201410005480A CN103705783A CN 103705783 A CN103705783 A CN 103705783A CN 201410005480 A CN201410005480 A CN 201410005480A CN 103705783 A CN103705783 A CN 103705783A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- rhizoma
- urination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 230000027939 micturition Effects 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title claims abstract description 22
- 206010013990 dysuria Diseases 0.000 title abstract description 6
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 241000241550 Cyathula Species 0.000 claims abstract description 3
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 2
- 240000001972 Gardenia jasminoides Species 0.000 claims description 2
- 241000025505 Pyrrosia Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 238000001035 drying Methods 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 238000010926 purge Methods 0.000 abstract description 3
- 241000906579 Actaea cimicifuga Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000183914 Dianthus superbus Species 0.000 abstract 1
- 235000013535 Dianthus superbus Nutrition 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241001116757 Pyrrosia lingua Species 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000003087 receptor blocking agent Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010071445 Bladder outlet obstruction Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000003800 Urinary Bladder Neck Obstruction Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 206010046459 urethral obstruction Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 5-25 parts of gardenia jasminoides ellis, 5-20 parts of cimicifuga foetida, 5-25 parts of polygonum aviculare, 5-20 parts of scutellaria baicalensis, 5-25 parts of fringed pink, 10-30 parts of rehmannia glutinosa libosch, 5-20 parts of rhizoma alismatis, 5-25 parts of golden cypress, 5-25 parts of bamboo leaf, 5-20 parts of medicinal cyathula root, 5-25 parts of radix scrophulariae, 5-20 parts of pericarpium citri reticulatae, 5-25 parts of yam rhizome, 10-30 parts of rhizoma atractylodis macrocephalae, 5-25 parts of rhizoma corydalis, 5-25 parts of pyrrosia lingua, 5-20 parts of codonopsis pilosula, 5-25 parts of eucommia ulmoides and 5-15 parts of liquorice. The traditional Chinese medicine composition has the effects of nourishing liver and kidney, clearing away heat and drying dampness, purging fire, removing toxin, nourishing yin, promoting the secretion of saliva or body fluid, and activating blood circulation to dissipate blood stasis. By utilizing the traditional Chinese medicine composition, effects for treating the frequent urination, urgent urination and painful urination caused by the benign prostatic hyperplasia are significant, and the effect is reliable.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind ofly treat the Chinese medicine composition that prostatic hyperplasia causes frequent micturition, urgent micturition, dysurea.
Background technology
Prostatic hyperplasia is elderly men common disease, its cause of disease is because prostatic increase gradually produces contention effect to urethra and bladder outlet, show as clinically frequent micturition, urgent micturition, dysurea, inferior the increasing and trouble urinating of urine at night, and can cause the complication such as urinary system infection, vesical calculus and hematuria, the quality of life of elderly men is produced and had a strong impact on, therefore need active treatment, some patients were even needs operative treatment.At present, the Drug therapy of LUTS/BPH standard comprises: α 1 receptor blocking agent, 5 alpha reductase inhibitors and the two therapeutic alliance.α 1 receptor blocking agent can reduce the tension force of prostate and urethral smooth muscle, thereby alleviates bladder outlet obstruction (BOO), is a line medication for the treatment of at present prostatic hyperplasia.Though α 1 receptor blocking agent can improve symptom and improve urine flow rate, but do not affect prostate volume, can not significantly control progression of disease, and α 1 receptor blocking agent can cause the untoward reaction such as the postural hypotension of human body, dizzy, weak, drowsiness, headache and defective ejaculation.5 alpha reductase inhibitors are by suppressing the activity of 5 alpha-reductases, reduce the content of dihydrotestosterone in prostate, and to reach the object that reduces prostate volume, but dwindling of prostate volume is slowly, and the alleviation of symptom at least needs 3-6 month.Meanwhile, 5 alpha reductase inhibitors also can bring to human body the side effect such as erection disturbance, hyposexuality, defective ejaculation and mammary gland pain.
The traditional Chinese medical science is thought, prostatic hyperplasia is to cause the enlargement of smart chamber by many reasons such as kidney unit virtual loss, deficiency of QI in middle-JIAO, overworked, eating and drinking without temperance, damp invasion of lower energizer, stagnation of QI due to depression of the liver and urethral obstructions, bladder qi dysfunction, take the disease that dysuria and urine retention be main clinical manifestation.
According to theory of Chinese medical science, for prostatic hyperplasia, cause the pathogeny of frequent micturition, urgent micturition, dysurea, take heat clearing and damp drying, eliminating fire and detoxication, Yin-nourishing and body fluid promoting, blood circulation promoting and blood stasis dispelling is Therapeutic Principle, carries out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome prior art western medicines in treatment prostatic hyperplasia, cause frequent micturition, urgent micturition, the deficiency that dysurea curative effect is slow, side effect is large, the invention provides a kind of Chinese medicine composition easy, that cost is low, evident in efficacy, treatment prostatic hyperplasia that have no side effect causes frequent micturition, urgent micturition, dysurea of preparing.
The technical solution adopted for the present invention to solve the technical problems is: a kind of prostatic hyperplasia for the treatment of causes frequent micturition, urgent micturition, the Chinese medicine composition of dysurea, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Fructus Gardeniae 5-25 part, Rhizoma Cimicifugae 5-20 part, Herba Polygoni Avicularis 5-25 part, Radix Scutellariae 5-20 part, Herba Dianthi 5-25 part, Radix Rehmanniae 10-30 part, Rhizoma Alismatis 5-20 part, Cortex Phellodendri 5-25 part, Folium Bambusae 5-25 part, Radix Cyathulae 5-20 part, Radix Scrophulariae 5-25 part, Pericarpium Citri Reticulatae 5-20 part, Rhizoma Dioscoreae Septemlobae 5-25 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Corydalis 5-25 part, Folium Pyrrosiae 5-25 part, Radix Codonopsis 5-20 part, Cortex Eucommiae 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind ofly treat the Chinese medicine composition that prostatic hyperplasia causes frequent micturition, urgent micturition, dysurea, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 15 parts of Fructus Gardeniaes, 10 parts of Rhizoma Cimicifugaes, 15 parts of Herba Polygoni Avicularis, 10 parts of Radix Scutellariaes, 15 parts of Herba Dianthis, 20 parts, the Radix Rehmanniae, 12 parts of Rhizoma Alismatis, 15 parts of Cortex Phellodendris, 15 parts, Folium Bambusae, 10 parts of Radix Cyathulaes, 15 parts of Radix Scrophulariae, 10 parts of Pericarpium Citri Reticulataes, 15 parts of Rhizoma Dioscoreae Septemlobae, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Corydalis, 15 parts of Folium Pyrrosiaes, 10 parts of Radix Codonopsis, 15 parts of the Cortexs Eucommiae, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Fructus Gardeniae has the effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Rhizoma Cimicifugae has the effect of the rash delivered, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy; Herba Polygoni Avicularis has inducing diuresis for treating stranguria syndrome, parasite killing, antipruritic effect; Radix Scutellariae has the effect of heat clearing and damp drying, eliminating fire and detoxication, arresting bleeding and miscarriage prevention; Herba Dianthi has the effect that inducing diuresis for treating stranguria syndrome, removing blood stasis stimulate the menstrual flow; The Radix Rehmanniae has the effect of clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, pain relieving regulating menstruation; Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, treating stranguria effect expels the heat-evil; Cortex Phellodendri has heat clearing and damp drying, pathogenic fire purging except steaming, the effect of detoxification sore treatment; Folium Bambusae has clearing heat and relieving fidgetness, the effect of the diuresis of promoting the production of body fluid; Radix Cyathulae has the effect of promoting blood circulation to restore menstrual flow, expelling wind and removing dampness, easing joint movement, inducing diuresis for treating stranguria syndrome; Radix Scrophulariae has that yin nourishing removing heat from blood, clearing away heat-fire, relieving restlessness quench the thirst, the effect of detoxicating and resolving stagnation of pathogens; Pericarpium Citri Reticulatae has the effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Rhizoma Dioscoreae Septemlobae has dampness removing and goes turbid, to dispel the wind blood stasis dispelling effect; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Rhizoma Corydalis has the effect of promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving; Folium Pyrrosiae has relieving stranguria by diuresis, the effect that lung heat clearing expels the heat-evil; Radix Codonopsis has the effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; The Cortex Eucommiae has the effect of invigorating the liver and kidney, bone and muscle strengthening, invigorating middle warmer benefit vital essence; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, help using mutual assistant, play altogether the effect of nourishing the liver and kidney, heat clearing and damp drying, eliminating fire and detoxication, Yin-nourishing and body fluid promoting, blood circulation promoting and blood stasis dispelling, prostatic hyperplasia is caused to the treatment of frequent micturition, urgent micturition, dysurea reaches treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 92%, cure rate 67%.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
embodiment 1
Treat prostatic hyperplasia and cause the Chinese medicine composition of frequent micturition, urgent micturition, dysurea, its raw material of Chinese medicine and weight proportion are: Fructus Gardeniae 15g, Rhizoma Cimicifugae 10g, Herba Polygoni Avicularis 15g, Radix Scutellariae 10g, Herba Dianthi 15g, Radix Rehmanniae 20g, Rhizoma Alismatis 12g, Cortex Phellodendri 15g, Folium Bambusae 15g, Radix Cyathulae 10g, Radix Scrophulariae 15g, Pericarpium Citri Reticulatae 10g, Rhizoma Dioscoreae Septemlobae 15g, Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Corydalis 15g, Folium Pyrrosiae 15g, Radix Codonopsis 10g, Cortex Eucommiae 15g, Radix Glycyrrhizae 10g.
embodiment 2
Treat prostatic hyperplasia and cause the Chinese medicine composition of frequent micturition, urgent micturition, dysurea, its raw material of Chinese medicine and weight proportion are: Fructus Gardeniae 10g, Rhizoma Cimicifugae 20g, Herba Polygoni Avicularis 5g, Radix Scutellariae 15g, Herba Dianthi 10g, Radix Rehmanniae 30g, Rhizoma Alismatis 5g, Cortex Phellodendri 25g, Folium Bambusae 10g, Radix Cyathulae 20g, Radix Scrophulariae 5g, Pericarpium Citri Reticulatae 15g, Rhizoma Dioscoreae Septemlobae 10g, Rhizoma Atractylodis Macrocephalae 30g, Rhizoma Corydalis 5g, Folium Pyrrosiae 25g, Radix Codonopsis 12g, Cortex Eucommiae 20g, Radix Glycyrrhizae 12g.
embodiment 3
Treat prostatic hyperplasia and cause the Chinese medicine composition of frequent micturition, urgent micturition, dysurea, its raw material of Chinese medicine and weight proportion are: Fructus Gardeniae 20g, Rhizoma Cimicifugae 12g, Herba Polygoni Avicularis 10g, Radix Scutellariae 20g, Herba Dianthi 5g, Radix Rehmanniae 25g, Rhizoma Alismatis 10g, Cortex Phellodendri 20g, Folium Bambusae 5g, Radix Cyathulae 12g, Radix Scrophulariae 10g, Pericarpium Citri Reticulatae 20g, Rhizoma Dioscoreae Septemlobae 5g, Rhizoma Atractylodis Macrocephalae 25g, Rhizoma Corydalis 10g, Folium Pyrrosiae 20g, Radix Codonopsis 5g, Cortex Eucommiae 10g, Radix Glycyrrhizae 6g.
embodiment 4
Treat prostatic hyperplasia and cause the Chinese medicine composition of frequent micturition, urgent micturition, dysurea, its raw material of Chinese medicine and weight proportion are: Fructus Gardeniae 5g, Rhizoma Cimicifugae 15g, Herba Polygoni Avicularis 25g, Radix Scutellariae 12g, Herba Dianthi 20g, Radix Rehmanniae 15g, Rhizoma Alismatis 15g, Cortex Phellodendri 10g, Folium Bambusae 20g, Radix Cyathulae 5g, Radix Scrophulariae 25g, Pericarpium Citri Reticulatae 12g, Rhizoma Dioscoreae Septemlobae 25g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Corydalis 20g, Folium Pyrrosiae 5g, Radix Codonopsis 15g, Cortex Eucommiae 25g, Radix Glycyrrhizae 5g.
embodiment 5
Treat prostatic hyperplasia and cause the Chinese medicine composition of frequent micturition, urgent micturition, dysurea, its raw material of Chinese medicine and weight proportion are: Fructus Gardeniae 25g, Rhizoma Cimicifugae 5g, Herba Polygoni Avicularis 20g, Radix Scutellariae 15g, Herba Dianthi 25g, Radix Rehmanniae 10g, Rhizoma Alismatis 20g, Cortex Phellodendri 5g, Folium Bambusae 25g, Radix Cyathulae 15g, Radix Scrophulariae 20g, Pericarpium Citri Reticulatae 5g, Rhizoma Dioscoreae Septemlobae 20g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Corydalis 25g, Folium Pyrrosiae 10g, Radix Codonopsis 20g, Cortex Eucommiae 5g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, after boiling with slow fire boiling 20～30 minutes; Decoct for the second time, add water and do not have approximately 4 centimetres of powder, after water boils, decoct 15～20 minutes.Decoct extracting juice twice, merge.
The present invention treats with given a kind of of embodiment 1 Chinese medicine composition that prostatic hyperplasia causes frequent micturition, urgent micturition, dysurea, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 examples, 50～75 years old age.
Two, diagnosis basis:
(1), dysuria, drop is not smooth, or urine obturation is obstructed, urethra is without puckery pain, little distention and fullness in the abdomen;
(2), male's rectal touch inspection can have prostate hyperplasia, or the obvious voiced sound of bladder area percussion;
(3), do the inspections such as cystoscope, B are super, abdominal part x line, help diagnosis.
Three, usage and dosage: during clinical practice, potion on the one, the about 400ml of twice extracting juice of decocting, minute morning, late twice empty stomach decoction being taken warmly.It within six days, is a course for the treatment of.The thing that period in a medicine avoids eating anything raw or cold, pungent, stimulation and fry, fire burn.
Four, criterion of therapeutical effect:
(1), cure: urine is unobstructed, and symptom and sign disappear;
(2), effective: symptom and sign are improved;
(3), do not heal: symptom is unchanged.
Five, therapeutic effect: in this clinical observation case, take medicine 2-5 the course for the treatment of, recovery from illness 67 examples, follow up a case by regular visits to and have no recurrence; Effective 25 examples, invalid 8 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Sui, man, 69 years old.Dysuria, drop is not smooth, little distention and fullness in the abdomen, xerostomia is wish drink not.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, slightly easily, lower abdomen sensation of fullness alleviates urine; After continuing to take 2 courses for the treatment of, urine is smooth and easy, and lower abdomen sensation of fullness disappears, and cures.
Case 2:
Cai, man, 57 years old.Urine is logical and not smooth suddenly, hypochondriac pain, urgency that lower abdomen is swollen, bitter taste.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, transference cure, continues to strengthen and takes 1 course for the treatment of, cures.
Claims (2)
1. treating prostatic hyperplasia causes and it is characterized in that the Chinese medicine composition of frequent micturition, urgent micturition, dysurea: its raw material of Chinese medicine and weight portion proportioning are: Fructus Gardeniae 5-25 part, Rhizoma Cimicifugae 5-20 part, Herba Polygoni Avicularis 5-25 part, Radix Scutellariae 5-20 part, Herba Dianthi 5-25 part, Radix Rehmanniae 10-30 part, Rhizoma Alismatis 5-20 part, Cortex Phellodendri 5-25 part, Folium Bambusae 5-25 part, Radix Cyathulae 5-20 part, Radix Scrophulariae 5-25 part, Pericarpium Citri Reticulatae 5-20 part, Rhizoma Dioscoreae Septemlobae 5-25 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Corydalis 5-25 part, Folium Pyrrosiae 5-25 part, Radix Codonopsis 5-20 part, Cortex Eucommiae 5-25 part, Radix Glycyrrhizae 5-15 part.
2. a kind ofly according to claim 1 treat the Chinese medicine composition that prostatic hyperplasia causes frequent micturition, urgent micturition, dysurea, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 15 parts of Fructus Gardeniaes, 10 parts of Rhizoma Cimicifugaes, 15 parts of Herba Polygoni Avicularis, 10 parts of Radix Scutellariaes, 15 parts of Herba Dianthis, 20 parts, the Radix Rehmanniae, 12 parts of Rhizoma Alismatis, 15 parts of Cortex Phellodendris, 15 parts, Folium Bambusae, 10 parts of Radix Cyathulaes, 15 parts of Radix Scrophulariae, 10 parts of Pericarpium Citri Reticulataes, 15 parts of Rhizoma Dioscoreae Septemlobae, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Corydalis, 15 parts of Folium Pyrrosiaes, 10 parts of Radix Codonopsis, 15 parts of the Cortexs Eucommiae, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005480.0A CN103705783A (en) | 2014-01-07 | 2014-01-07 | Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005480.0A CN103705783A (en) | 2014-01-07 | 2014-01-07 | Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103705783A true CN103705783A (en) | 2014-04-09 |
Family
ID=50399370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005480.0A Pending CN103705783A (en) | 2014-01-07 | 2014-01-07 | Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705783A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906463A (en) * | 2015-06-10 | 2015-09-16 | 徐如阳 | Traditional Chinese medicine combination for treating frequent micturition, urgent urination and micturition pain |
| CN110201053A (en) * | 2019-07-15 | 2019-09-06 | 河南白马健康产业有限公司 | One seedling medicine paste for treating prostate and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1753682A (en) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | Herbal composition for prostate disease |
| CN1765396A (en) * | 2005-09-28 | 2006-05-03 | 李亚萍 | Chinese herbal decoction for treating damp heat downward flow pattern prostatitis and preparation method |
| CN103142826A (en) * | 2013-04-05 | 2013-06-12 | 李承平 | Poison yam strangury freeing tablet |
-
2014
- 2014-01-07 CN CN201410005480.0A patent/CN103705783A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1753682A (en) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | Herbal composition for prostate disease |
| CN1765396A (en) * | 2005-09-28 | 2006-05-03 | 李亚萍 | Chinese herbal decoction for treating damp heat downward flow pattern prostatitis and preparation method |
| CN103142826A (en) * | 2013-04-05 | 2013-06-12 | 李承平 | Poison yam strangury freeing tablet |
Non-Patent Citations (2)
| Title |
|---|
| 李昌勤等: "八正散的现代临床应用概述", 《中成药》 * |
| 郑伟达: "《前列腺增生症针灸治疗》", 《中国针灸学会年会论文集（摘要）》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906463A (en) * | 2015-06-10 | 2015-09-16 | 徐如阳 | Traditional Chinese medicine combination for treating frequent micturition, urgent urination and micturition pain |
| CN110201053A (en) * | 2019-07-15 | 2019-09-06 | 河南白马健康产业有限公司 | One seedling medicine paste for treating prostate and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN1315526C (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN104042957A (en) | Traditional Chinese medicine (TCM) composition for treating prostatitis | |
| CN102988672B (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN104740202A (en) | Medicine for treating skin itch | |
| CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN102949569B (en) | Traditional Chinese medicine composition for treating frequent micturition, urgent urination and micturition pain caused by benign prostatic hyperplasia | |
| CN101422554B (en) | Traditional Chinese medicine for treating acne | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
| CN103393989A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
| CN104324340A (en) | Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation | |
| CN103394030B (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
| CN104306848A (en) | Traditional Chinese medicinal composition for treating frequent micturition caused by deficiency of kidney | |
| CN104043010A (en) | Traditional Chinese medicine (TCM) composition for treating prostatitis | |
| CN103705659A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN103463397B (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
| CN102091193B (en) | Oral medicine for treating urolithiasis | |
| CN105213831A (en) | A kind of Chinese medicine composition for the treatment of epidemic hemorrhagic fever | |
| CN103536856B (en) | A kind of Chinese medicine composition for the treatment of lower abdominal pain | |
| CN103735998A (en) | Traditional Chinese medicinal composition for treating haemorrhoids | |
| CN103212013A (en) | Chinese medicinal composition for treating epigastric pain | |
| CN103816288A (en) | Traditional Chinese medicine composition for treating urinary tract inflammations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140409 |
|
| WD01 | Invention patent application deemed withdrawn after publication |